| Financial Year |
March 31 2023 |
| Monetary Funds |
562,673,503.80 |
| Held-for-trading Financial Assets |
116,050,000.00 |
| Notes Receivable |
241,872,188.10 |
| Accounts Receivable |
825,907,422.09 |
| Advances to Suppliers |
18,870,990.91 |
| Other Receivables |
83,552,857.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
587,812,490.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,044,123.76 |
| Total Current Assets |
2,445,783,576.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,438,952.73 |
| Investment Properties |
102,028,159.73 |
| Fixed Assetes |
429,097,688.77 |
| Under-construction Projects |
112,270,575.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,282,905.54 |
| R&D expenses |
10,585,516.73 |
| Goodwill |
858,423,002.53 |
| Long-Term Deferred and Prepaid Expenses |
4,109,676.17 |
| Deferred Income Tax Assets |
82,603,268.19 |
| Other Non-Current Assets |
39,396,530.83 |
| Sub-Total of Non-Current Assets |
1,788,829,946.03 |
| Total Assets |
4,234,613,522.92 |
| Short-Term Loans |
124,412,106.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
286,145,794.14 |
| Accounts Payable |
350,772,236.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,639,304.63 |
| Taxes Payable |
27,107,830.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,036,128.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,438,711.14 |
| Other Current Liabilities |
85,733.43 |
| Sub-Total of Current Liabilities |
836,686,366.00 |
| Long-term Loans |
21,139,549.47 |
| Bonds Payable |
50,188,693.07 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
37,639,657.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
176,028,519.99 |
| Total Liabilities |
1,012,714,885.99 |
| Paid-In Capital(Or Share Stock) |
913,367,377.00 |
| Capital Surplus |
2,158,294,461.80 |
| Surplus Reserve |
67,734,444.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
63,303,095.94 |
| Minority Stockholder's Interest |
3,378,214.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,218,520,422.81 |
| Owner's Equity（Stockholder's Equity） |
3,221,898,636.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,234,613,522.92 |
